EMA
- Application: EMEA/H/C/005746
- Marketing authorisation holder: GlaxoSmithKline Trading Services Limited
- Local brand name: Jesduvroq
- Indication: Treatment of anaemia associated with chronic kidney disease (CKD) in adults.
- Status: withdrawn
🇪🇺 Jesduvroq in European Union
Jesduvroq (DAPRODUSTAT) regulatory status in European Union.
Marketing authorisation
Jesduvroq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in European Union
Frequently asked questions
Is Jesduvroq approved in European Union?
Yes. EMA has authorised it.
Who is the marketing authorisation holder for Jesduvroq in European Union?
GlaxoSmithKline Trading Services Limited holds the EU marketing authorisation.